Business Description
Lite Strategy Inc
NAICS : 325412
SIC : 2834
ISIN : US55279B3015
Total Employee Number:
4Description
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 40.2 | |||||
3-Year EPS without NRI Growth Rate | 43 | |||||
3-Year FCF Growth Rate | 26.5 | |||||
3-Year Book Growth Rate | -31.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 20.06 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.92 | |||||
9-Day RSI | 58.73 | |||||
14-Day RSI | 53.46 | |||||
3-1 Month Momentum % | -34.32 | |||||
6-1 Month Momentum % | -51.38 | |||||
12-1 Month Momentum % | -72.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.53 | |||||
Quick Ratio | 11.53 | |||||
Cash Ratio | 10.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -293.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -105.8 | |||||
ROA % | -103.74 | |||||
ROIC % | -26.86 | |||||
3-Year ROIIC % | -291.72 | |||||
ROC (Joel Greenblatt) % | -1032.3 | |||||
ROCE % | -21.05 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 0.6 | |||||
EV-to-EBIT | 0.42 | |||||
EV-to-EBITDA | 0.42 | |||||
EV-to-Forward-Revenue | 0.68 | |||||
EV-to-FCF | 0.49 | |||||
| Price-to-Net-Current-Asset-Value | 3.36 | |||||
| Price-to-Net-Cash | 3.89 | |||||
Earnings Yield (Greenblatt) % | 238.1 | |||||
FCF Yield % | -31.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LITS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lite Strategy Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2 | ||
| Beta | 0.4857 | ||
| 3-Year Sharpe Ratio | -0.47 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 131.11 | ||
| 14-Day RSI | 53.46 | ||
| 14-Day ATR ($) | 0.081941 | ||
| 20-Day SMA ($) | 0.84705 | ||
| 12-1 Month Momentum % | -72.06 | ||
| 52-Week Range ($) | 0.6888 - 9 | ||
| Shares Outstanding (Mil) | 34.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lite Strategy Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lite Strategy Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings results for 2027 | 2026-11-13 | In 129 days | ||
| Annual report for 2026 | 2026-09-25 | In 80 days | ||
| Third quarter earnings results for 2026 | 2026-05-13 | 1.25 (+2.46%) | ||
| Second quarter earnings results for 2026 | 2026-02-17 | 1.12 (+5.66%) | ||
| General meeting for 2026 | 2026-02-12 09:00 | 1.07 (+2.88%) | ||
| First quarter earnings results for 2026 | 2025-11-14 | 1.90 (-5.00%) | ||
| Annual report for 2025 | 2025-09-26 | 2.54 (-4.51%) | ||
| Third quarter earnings results for 2025 | 2025-05-13 | 2.09 (+1.70%) | ||
| Second quarter earnings results for 2025 | 2025-02-12 | 2.71 (-0.55%) | ||
| General meeting for 2025 | 2025-01-30 09:00 | 2.88 (-0.03%) |
Show
Entries
Lite Strategy Inc Frequently Asked Questions
What is Lite Strategy Inc(LITS)'s stock price today?
The current price of LITS is $0.97. The 52 week high of LITS is $9.00 and 52 week low is $0.69.
When is next earnings date of Lite Strategy Inc(LITS)?
The next earnings date of Lite Strategy Inc(LITS) is 2026-08-13 Est..
Does Lite Strategy Inc(LITS) pay dividends? If so, how much?
Lite Strategy Inc(LITS) does not pay dividend.
Guru Commentaries on NAS:LITS
No articles.
Press Release
Articles on Lite Strategy Inc
No articles.
Headlines
See More- 1
Jun 18, 2026
Lite Strategy Leads Strategic Investment in LitVM
Benzinga • 7:30am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers